Recruiting IgA Nephropathy Studies in Iowa City
About IgA Nephropathy Clinical Trials in Iowa City
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 2 iga nephropathy clinical trials recruiting participants in Iowa City, IA. These studies are seeking a combined 77 participants. Research is being sponsored by ADARx Pharmaceuticals, Inc., Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in Iowa City — FAQ
Are there iga nephropathy clinical trials in Iowa City?
Yes, there are 2 iga nephropathy clinical trials currently recruiting in Iowa City, IA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Iowa City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.
Are clinical trials in Iowa City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 2 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated July 13, 2026 from ClinicalTrials.gov